MiNA Therapeutics

About:

MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms.

Website: http://www.minatx.com

Twitter/X: mina_tx

Top Investors: Eli Lilly, aMoon Fund, Sosei Group

Description:

MiNA Therapeutics is a clinical-stage biotechnology company developing therapeutic medicines to harness gene activation mechanisms. Its technology helps transform the therapy landscape of cancer and other severe diseases that enable doctors and physicians to cure diseases and develop medicines that restore normal function to patients' cells. The company was founded in 2008 and is headquartered in London, England.

Total Funding Amount:

$89.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2008-01-01

Contact Email:

info(AT)minatx.com

Founders:

John J. Rossi, Nagy Habib, Pål Sætrom

Number of Employees:

11-50

Last Funding Date:

2021-07-06

IPO Status:

Private

Industries:

© 2025 bioDAO.ai